Unexpected remission of renal AA amyloidosis associated with rheumatoid arthritis

Joint Bone Spine

Volumn 76, Issue 4, 2009, Pages 431-432

  Millet, Arnaud ^a   Rioux Leclercq, Nathalie ^a,b   Le Lay, Jean pierre ^c   Le Pogamp, Patrick ^a,b   Vigneau, Cécile ^a,b  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c Rennes 1 University ^*  (France)

Author keywords

AA amyloidosis; Bone marrow suppression; Renal failure; Rheumatoid arthritis

Indexed keywords

CHLORAMBUCIL; GOLD SALT; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; SALAZOSULFAPYRIDINE; TIOPRONIN;

ADULT; BONE MARROW SUPPRESSION; CASE REPORT; FEMALE; HISTOLOGY; HUMAN; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; KIDNEY FUNCTION; LETTER; OUTCOME ASSESSMENT; PROGNOSIS; PROTEINURIA; REMISSION; RHEUMATOID ARTHRITIS;

ADULT; AMYLOIDOSIS; ANTINEOPLASTIC AGENTS, ALKYLATING; ARTHRITIS, RHEUMATOID; CHLORAMBUCIL; FEMALE; HUMANS; KIDNEY DISEASES; PROGNOSIS; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 67649828018     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2008.12.003     Document Type: Letter

References (8)

1. Gertz M.A., and Kyle R.A. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine 70 (1991) 246-256
2. Lachman H.J., Goodman H.J.B., Gilbertson J.A., et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med 356 (2007) 2361-2371
3. Joss N., McLaughlin, Simpson K., et al. Presentation, survival and prognostic markers in AA amyloidosis. Q J Med 93 (2000) 535-542
4. Verine J., Mourad N., Desseaux K., et al. Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response. Hum Pathol 38 (2007) 1798-1809
5. Gilmore J.D., Lovat L.B., Persey M.R., et al. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 358 (2001) 24-29
6. Ortiz-Santamaria V., Olivé A., Valls-Roc M., et al. Treatment of AA amyloid with chlorambucil. Rheumatology 41 (2002) 833
7. Gottenberg J.E., Merle-Vincent F., Bentaberry F., et al. Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy. Arthritis Rheum 48 (2003) 2019-2024
8. Burt R., Loh Y., Pearce W., et al. Clinical applications of blood-derived and marrow-derived stem cells for non-malignant diseases. JAMA 299 (2008) 925-936